Patenting Stem Cells
November 2009. Today, it is still rather difficult to predict the chances of receiving the grant of a patent for stem cell technologies. Sebastian Tegethoff is a young developmental biologist and patent attorney. In this peer-reviewed and revised article he leaves aside lawyers’ advertorials in order to discuss the material meaning of biological objects which underlie legal terms, provisions, or individual litigation.Reading time: 14 min
Read Now: |
Other articles recommended
B2Bioworld offers you background information
Stem Cells – Failings and Deliveries
Strategic ambiguities with "stem cells"
Bernd Kirschbaum,Global Discovery and Early Development Merck Serono on strategic ambiguities in technology development
Bayer AG: New stakes in stem cells
Andreas Busch, Head of Global Drug Discovery on results, technology platforms, and expectations
Boehringer Ingelheim: Embryonic stem cells and animal models
Andreas Barner, Chairman Boehringer Ingelheim and Head of Pharma Research
Thinking Further About Stem Cells - Viewed from Systems Biology
Leroy Hood, President Institute for Systems Biology, Seattle, Washington (US)